Table 4.

Multi-Regression analysis of associations between cumulative doxorubicin dose and percent decline in RV function parameters

	Coefficient	p-value
ΔRV FAC (%)	0.404	0.045
ΔRV FWS (%)	0.420	0.028
ΔRV GLS (%)	0.907	0.373
Model adjusted for age, BMI, COPD, pulmonary hypertension, DLD, HTN, diabetes, heart rate during echocardiography

BMI Body Mass Index, COPD chronic obstructive pulmonary disease, DLD Dyslipidemia, Echo Echocardiogram, LVEF Left ventricular ejection fraction, RVFAC Right ventricular fractional area change, RVFWS Right ventricular free wall strain, RVGLS Right ventricular global longitudinal strain